|
| 34671754 | Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. | Cell Rep Methods | 2021 |
| 32019188 | Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)<sub>n</sub> Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors? | Int J Mol Sci | 2020 |
| 31467290 | A dataset describing a suite of novel antibody reagents for the RAS signaling network. | Sci Data | 2019 |
| 29359686 | Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins. | Elife | 2018 |
| 29928062 | Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. | PLoS One | 2018 |
| 29899869 | Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics. | Oncotarget | 2018 |
| 29718670 | Evaluation of NCI-7 Cell Line Panel as a Reference Material for Clinical Proteomics. | Journal of Proteome Research | 2018 |
| 29610327 | Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation/modification cross-talk. | Proc Natl Acad Sci U S A | 2018 |
| 29474155 | A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. | Radiat Res | 2018 |
| 29638227 | A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors. | Nat Methods | 2018 |
| 28951536 | Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies. | Sci Signal | 2017 |
| 27894102 | Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface. | Oncotarget | 2016 |
| 26867747 | Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays. | Methods Mol Biol | 2016 |
| 26719571 | Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. | Clin Chem | 2016 |
| 25512614 | Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. | Molecular and Cellular Proteomics | 2015 |
| 24443746 | Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. | Mol Cell Proteomics | 2014 |
| 21137080 | Characterizations and validations of novel antibodies toward translational research. | Proteomics Clin Appl | 2010 |
| 19389551 | Analytical considerations for mass spectrometry profiling in serum biomarker discovery. | Clinics in Laboratory Medicine | 2009 |
| 18336391 | Ovarian cancer in the proteomics era. | International Journal of Gynecological Cancer | 2008 |
| 19325937 | Bringing diagnostic technologies to the clinical laboratory: Rigor, regulation, and reality. | Proteomics - Clinical Applications | 2008 |
| 18057524 | Proteomics as a tool for biomarker discovery. | Disease Markers | 2007 |
| 17952875 | Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications. | Proteomics | 2007 |
| 17854367 | Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis. | Br J Dermatol | 2007 |
| 17463175 | A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. | Clin Chem | 2007 |
| 17594124 | Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer. | Ann Surg Oncol | 2007 |
| 17933009 | A robust biomarker discovery pipeline for high-performance mass spectrometry data. | Journal of Bioinformatics and Computational Biology | 2007 |
| 16880955 | Proteomic patterns for cancer diagnosis--promise and challenges. | Molecular BioSystems | 2006 |
| 17139365 | SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occurring before age 40. | Thrombosis and Haemostasis | 2006 |
| 16704202 | Fractionation of serum components using nanoporous substrates. | Bioconjug Chem | 2006 |
| 16452246 | Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. | Cancer Res | 2006 |
| 16737951 | Proteomics in clinical trials and practice: present uses and future promise. | Molecular and Cellular Proteomics | 2006 |
| 16728285 | Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. | Exp Hematol | 2006 |
| 16081505 | High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. | Clin Chem | 2005 |
| 15251975 | Clinical proteomics and biomarker discovery. | Ann N Y Acad Sci | 2004 |
| 15258334 | Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients. | Dis Markers | 2003 |
| 11687474 | Recognition of multiple classes of hepatitis C antibodies increases detection sensitivity in oral fluid. | Clinical and Diagnostic Laboratory Immunology | 2001 |